Fortitude Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History

Fortitude Advisory Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-371	Closed	-$48K	–	680
2022 Q1	$48K	Hold	371	–	–	0.03%	548
2021 Q4	$57K	Buy	+371	New	+$57.4K	0.03%	506

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Fortitude Advisory Group's IBB Position: Q2 2022 in Review

Fortitude Advisory Group sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 371 shares — an estimated $48K sold.

Fortitude Advisory Group first reported a position in IBB in Q4 2021 and held it in 2 quarters. The position peaked at $57K in Q4 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Fortitude Advisory Group reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Fortitude Advisory Group sold 371 iShares Biotechnology ETF shares in Q2 2022, an estimated $48K.
Fortitude Advisory Group first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 2 quarters.
Fortitude Advisory Group's iShares Biotechnology ETF position peaked at $57K in Q4 2021.
858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.